In case you missed it: July 5 to July 9

Article

It was a very busy week for the Contemporary OB/GYN® team.

This week’s top articles included:

Surprise bills for childbirth

In addition to welcoming a newborn, parents may be unexpectedly billed for some hospitalization services, according to a research letter in JAMA Health Forum.

Novel antifungal treatment approved for vaginal candidiasis

On June 2, 2021, ibrexafungerp (Brexafemme; Scynexis, Inc) was approved by the Food and Drug Administration for vulvovaginal candidiasis (VVC) in adult women and pediatric females who have begun menstruating. Ibrexafungerp is a triterpenoid antifungal that works by inhibiting the formation of the fungal cell wall. Ibrexafungerp (pronounced eye-BREX-ah-FUN-jerp) is the first approved drug of a novel class of antifungals.

Visual Summary: Intrahepatic Cholestasis of Pregnancy

Refer to this visual summary from SMFM wherever you practice.

Meet the Board: Yalda Afshar, MD, PhD

Introducing Contemporary OB/GYN® Editorial Advisory Board member Yalda Afshar, MD, PhD.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Ciera Kirkpatrick, PhD, shows how TikTok is transforming cervical cancer awareness | Image Credit: linkedin.com.
Maria Gallo, PhD, discusses high attendance at crisis pregnancy centers | Image Credit: © x.com.
© 2025 MJH Life Sciences

All rights reserved.